デフォルト表紙
市場調査レポート
商品コード
1306192

NGSベースのRNAシークエンシング市場:製品・サービス、技術、用途、エンドユーザー別-2023-2030年の世界予測

NGS-Based RNA-Sequencing Market by Product & Services, Technology, Application, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
NGSベースのRNAシークエンシング市場:製品・サービス、技術、用途、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

NGSベースのRNAシークエンシングの世界市場は、2023年にCAGR 22.23%で16億301万米ドルが予測され、2030年には65億6,155万米ドルという驚異的な規模に達する見込みで、大きな成長が予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界のNGSベースのRNAシークエンシング市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展:有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化:新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向:COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報:主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション:将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします:

1.NGSベースのRNAシークエンシングの世界市場規模および予測は?

2.予測期間中、世界のNGSベースのRNAシークエンシング市場を形成するCOVID-19の阻害要因と影響は?

3.NGSベースのRNAシークエンシングの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は?

4.NGSベースのRNAシークエンシングの世界市場における競争戦略は?

5.NGSベースのRNAシークエンシングの世界市場における技術動向と規制の枠組みは?

6.NGSベースのRNAシークエンシングの世界市場における主要ベンダーの市場シェアは?

7.NGSベースのRNAシークエンシングの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 次世代シーケンスの導入が急増
      • 精密医療の堅調な成長とRNAシーケンス補助金の増加
      • 高度なシーケンスベースの診断に対する需要の増加
    • 抑制要因
      • NGS装置のコストは高い
    • 機会
      • RNAシーケンスにおける技術の進歩
      • RNAシーケンスに関連する調査活動の増加
    • 課題
      • 熟練した人材の不足
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 NGSベースのRNAシークエンシング市場製品とサービス別

  • データ分析
  • RNAシーケンスプラットフォームと消耗品
  • RNAシーケンスサービス
  • サンプル調製製品
  • ストレージと管理

第7章 NGSベースのRNAシークエンシング市場:技術別

  • イオン半導体シーケンス
  • ナノポアシーケンシング
  • 合成別シーケンス
  • 単一分子のリアルタイムシーケンス

第8章 NGSベースのRNAシークエンシング市場:用途別

  • De Novoトランスクリプトームアセンブリ
  • 式プロファイリング分析
  • Small RNAシーケンス
  • バリアントコーリングとトランスクリプトームのエピジェネティクス

第9章 NGSベースのRNAシークエンシング市場:エンドユーザー別

  • 病院とクリニック
  • 製薬およびバイオテクノロジー企業
  • 調査と学術

第10章 南北アメリカのNGSベースのRNAシークエンシング市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のNGSベースのRNAシークエンシング市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのNGSベースのRNAシークエンシング市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析:主要企業別
  • 競合シナリオ分析:主要企業別

第14章 掲載企業一覧

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. NGS-BASED RNA-SEQUENCING MARKET RESEARCH PROCESS
  • FIGURE 2. NGS-BASED RNA-SEQUENCING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. NGS-BASED RNA-SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2022 VS 2030 (%)
  • FIGURE 5. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
  • FIGURE 6. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 8. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 9. NGS-BASED RNA-SEQUENCING MARKET DYNAMICS
  • FIGURE 10. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 18. NGS-BASED RNA-SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 19. NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. NGS-BASED RNA-SEQUENCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. NGS-BASED RNA-SEQUENCING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 5. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DATA ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING PLATFORMS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RNA SEQUENCING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SAMPLE PREPARATION PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STORAGE & MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 11. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY ION SEMICONDUCTOR SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY NANOPORE SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SEQUENCING BY SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SINGLE-MOLECULE REAL-TIME SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY DE NOVO TRANSCRIPTOME ASSEMBLY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY EXPRESSION PROFILING ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY SMALL RNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY VARIANT CALLING & TRANSCRIPTOME EPIGENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NGS-BASED RNA-SEQUENCING MARKET SIZE, BY RESEARCH & ACADEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MEXICO NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. AUSTRALIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. CHINA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. INDIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDONESIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. JAPAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. MALAYSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. PHILIPPINES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SINGAPORE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH KOREA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TAIWAN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. THAILAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. VIETNAM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. DENMARK NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. EGYPT NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. FINLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. FRANCE NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. GERMANY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. ISRAEL NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. ITALY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. NETHERLANDS NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. NIGERIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. NORWAY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. POLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. QATAR NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. RUSSIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. SAUDI ARABIA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. SOUTH AFRICA NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 171. SPAIN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. SWEDEN NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWITZERLAND NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. TURKEY NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED ARAB EMIRATES NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY PRODUCT & SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED KINGDOM NGS-BASED RNA-SEQUENCING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 192. NGS-BASED RNA-SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 193. NGS-BASED RNA-SEQUENCING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 194. NGS-BASED RNA-SEQUENCING MARKET LICENSE & PRICING
目次
Product Code: MRR-2214614769E9

The Global NGS-Based RNA-Sequencing Market is forecasted to grow significantly, with a projected USD 1,603.01 million in 2023 at a CAGR of 22.23% and expected to reach a staggering USD 6,561.55 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global NGS-Based RNA-Sequencing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global NGS-Based RNA-Sequencing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product & Services, market is studied across Data Analysis, RNA Sequencing Platforms & Consumables, RNA Sequencing Services, Sample Preparation Products, and Storage & Management. The Data Analysis is projected to witness significant market share during forecast period.

Based on Technology, market is studied across Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing By Synthesis, and Single-Molecule Real-Time Sequencing. The Sequencing By Synthesis is projected to witness significant market share during forecast period.

Based on Application, market is studied across De Novo Transcriptome Assembly, Expression Profiling Analysis, Small RNA Sequencing, and Variant Calling & Transcriptome Epigenetics. The De Novo Transcriptome Assembly is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research & Academia. The Research & Academia is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global NGS-Based RNA-Sequencing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global NGS-Based RNA-Sequencing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global NGS-Based RNA-Sequencing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global NGS-Based RNA-Sequencing Market?

4. What is the competitive strategic window for opportunities in the Global NGS-Based RNA-Sequencing Market?

5. What are the technology trends and regulatory frameworks in the Global NGS-Based RNA-Sequencing Market?

6. What is the market share of the leading vendors in the Global NGS-Based RNA-Sequencing Market?

7. What modes and strategic moves are considered suitable for entering the Global NGS-Based RNA-Sequencing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. NGS-Based RNA-Sequencing Market, by Product & Services, 2022 vs 2030
  • 4.3. NGS-Based RNA-Sequencing Market, by Technology, 2022 vs 2030
  • 4.4. NGS-Based RNA-Sequencing Market, by Application, 2022 vs 2030
  • 4.5. NGS-Based RNA-Sequencing Market, by End-User, 2022 vs 2030
  • 4.6. NGS-Based RNA-Sequencing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Surge in the adoption of next-generation sequencing
      • 5.1.1.2. Robust growth of precision medicines and rising amount of RNA sequencing grants
      • 5.1.1.3. Increasing demand for advanced sequencing-based diagnostics
    • 5.1.2. Restraints
      • 5.1.2.1. Cost of NGS instruments is high
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the RNA-Sequencing
      • 5.1.3.2. Increasing research activities related to RNA-Sequencing
    • 5.1.4. Challenges
      • 5.1.4.1. Unavailability of skilled manpower
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. NGS-Based RNA-Sequencing Market, by Product & Services

  • 6.1. Introduction
  • 6.2. Data Analysis
  • 6.3. RNA Sequencing Platforms & Consumables
  • 6.4. RNA Sequencing Services
  • 6.5. Sample Preparation Products
  • 6.6. Storage & Management

7. NGS-Based RNA-Sequencing Market, by Technology

  • 7.1. Introduction
  • 7.2. Ion Semiconductor Sequencing
  • 7.3. Nanopore Sequencing
  • 7.4. Sequencing By Synthesis
  • 7.5. Single-Molecule Real-Time Sequencing

8. NGS-Based RNA-Sequencing Market, by Application

  • 8.1. Introduction
  • 8.2. De Novo Transcriptome Assembly
  • 8.3. Expression Profiling Analysis
  • 8.4. Small RNA Sequencing
  • 8.5. Variant Calling & Transcriptome Epigenetics

9. NGS-Based RNA-Sequencing Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals & Clinics
  • 9.3. Pharmaceutical & Biotechnology Companies
  • 9.4. Research & Academia

10. Americas NGS-Based RNA-Sequencing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific NGS-Based RNA-Sequencing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa NGS-Based RNA-Sequencing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing